Search

Your search keyword '"Bashton, M"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Bashton, M" Remove constraint Author: "Bashton, M"
82 results on '"Bashton, M"'

Search Results

1. Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement

2. Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: multicenter, prospective study

3. MODELLING THE CLONAL EVOLUTION OF BURKITT LYMPHOMA USING PATIENT-DERIVED XENOGRAFTS

4. SARS-CoV-2 evolution during treatment of chronic infection

5. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2

7. Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement

8. Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse

9. Spatio-temporal epidemiology of SARS-CoV-2 virus lineages in Teesside, UK, in 2020: effects of social deprivation, weather and lockdown on lineage dynamics

11. Genomic reconstruction of the SARS-CoV-2 epidemic in England

12. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

13. Bacterial Diversity in House Dust: Characterization of a Core Indoor Microbiome

14. An integrated national scale SARS-CoV-2 genomic surveillance network

16. The role of the RAS pathway in iAMP21-ALL

17. PS921 INACTIVATION OF SH2B3 THROUGH CN-LOH 12Q IS UNIQUELY ASSOCIATED WITH B-CELL PRECURSOR ALL WITH IAMP21 OR OTHER CHROMOSOME 21 GAIN

19. Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures

20. Integrated pathway analysis of malignant rhabdoid tumour identifies key SMARCB1-pathways and therapeutic opportunities

21. Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost, mass spectrometry-based DNA methylomics

26. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

28. Genomic reconstruction of the SARS-CoV-2 epidemic in England

29. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

30. Recurrent SARS-CoV-2 mutations in immunodeficient patients

31. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2

32. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

33. Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning

34. The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis

35. Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer

36. Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021

37. Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement

38. IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia

39. TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication.

40. Addressing pandemic-wide systematic errors in the SARS-CoV-2 phylogeny.

41. ProCogGraph: a graph-based mapping of cognate ligand domain interactions.

42. OMEinfo: global geographic metadata for -omics experiments.

43. Environmental microbiome in the home and daycare settings during the COVID-19 pandemic, and potential risk of non-communicable disease in children.

44. Prevalence of persistent SARS-CoV-2 in a large community surveillance study.

45. Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A .

46. Lineage replacement and evolution captured by 3 years of the United Kingdom Coronavirus (COVID-19) Infection Survey.

47. Correction: Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias.

48. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.

49. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.

50. Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias.

Catalog

Books, media, physical & digital resources